Medartis Holding AG (SWX:MED)

Market Cap	1.02B -5.5%
Revenue (ttm)	307.05M +29.9%
Net Income	14.92M
EPS	1.20
Shares Out	12.45M
PE Ratio	68.39
Forward PE	46.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	63,689
Open	81.20
Previous Close	82.00
Day's Range	81.20 - 82.80
52-Week Range	70.60 - 97.50
Beta	1.17
Analysts	Strong Buy
Price Target	108.75 (+32.46%)
Earnings Date	Mar 2, 2027

About Medartis Holding AG

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company’s medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 1,428
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: MED

Financial Performance

In 2025, Medartis Holding AG's revenue was 269.26 million, an increase of 19.76% compared to the previous year's 224.83 million. Earnings were 8.35 million, an increase of 136.65%.

Analyst Summary

According to 4 analysts, the average rating for MED stock is "Strong Buy." The 12-month stock price target is CHF 108.75, which is an increase of 32.46% from the latest price.

Price Target

CHF 108.75

(32.46% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 2, 2026

Data Sources Report a data error